Biochemistry (Washington) 2013-12-23

The human liver fatty acid binding protein T94A variant alters the structure, stability, and interaction with fibrates.

Gregory G Martin, Avery L McIntosh, Huan Huang, Shipra Gupta, Barbara P Atshaves, Kerstin K Landrock, Danilo Landrock, Ann B Kier, Friedhelm Schroeder

Index: Biochemistry 52(51) , 9347-57, (2013)

Full Text: HTML

Abstract

Although the human liver fatty acid binding protein (L-FABP) T94A variant arises from the most commonly occurring single-nucleotide polymorphism in the entire FABP family, there is a complete lack of understanding regarding the role of this polymorphism in human disease. It has been hypothesized that the T94A substitution results in the complete loss of ligand binding ability and function analogous to that seen with L-FABP gene ablation. This possibility was addressed using the recombinant human wild-type (WT) T94T and T94A variant L-FABP and cultured primary human hepatocytes. Nonconservative replacement of the medium-sized, polar, uncharged T residue with a smaller, nonpolar, aliphatic A residue at position 94 of the human L-FABP significantly increased the L-FABP α-helical structure content at the expense of β-sheet content and concomitantly decreased the thermal stability. T94A did not alter the binding affinities for peroxisome proliferator-activated receptor α (PPARα) agonist ligands (phytanic acid, fenofibrate, and fenofibric acid). While T94A did not alter the impact of phytanic acid and only slightly altered that of fenofibrate on the human L-FABP secondary structure, the active metabolite fenofibric acid altered the T94A secondary structure much more than that of the WT T94T L-FABP. Finally, in cultured primary human hepatocytes, the T94A variant exhibited a significantly reduced extent of fibrate-mediated induction of PPARα-regulated proteins such as L-FABP, FATP5, and PPARα itself. Thus, while the T94A substitution did not alter the affinity of the human L-FABP for PPARα agonist ligands, it significantly altered the human L-FABP structure, stability, and conformational and functional response to fibrate.


Related Compounds

  • Fenofibrate
  • Phytanic acid

Related Articles:

Pharmacological protection of retinal pigmented epithelial cells by sulindac involves PPAR-α.

2014-11-25

[Proc. Natl. Acad. Sci. U. S. A. 111(47) , 16754-9, (2014)]

Modulators of hepatic lipoprotein metabolism identified in a search for small-molecule inducers of tribbles pseudokinase 1 expression.

2015-01-01

[PLoS ONE 10 , e0120295, (2015)]

Hypolipidemic and Hepatic Steatosis Preventing Activities of the Wood Ear Medicinal Mushroom Auricularia auricula-judae (Higher Basidiomycetes) Ethanol Extract In Vivo and In Vitro.

2015-01-01

[Int. J. Med. Mushrooms 17 , 723-34, (2015)]

Gastrointestinal behavior of nano- and microsized fenofibrate: In vivo evaluation in man and in vitro simulation by assessment of the permeation potential.

2015-09-18

[Eur. J. Pharm. Sci. 77 , 40-7, (2015)]

BFCOD activity in fish cell lines and zebrafish embryos and its modulation by chemical ligands of human aryl hydrocarbon and nuclear receptors.

2015-11-01

[Environ. Sci. Pollut. Res. Int. 22 , 16393-404, (2015)]

More Articles...